Canandaigua National Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.01M Buy
+7,511
New +$7.67M 0.76% 28
2025
Q4
$9.36M Sell
8,708
-284
-3% -$272K 0.84% 25
2025
Q3
$6.86M Buy
8,992
+833
+10% +$620K 0.6% 34
2025
Q2
$6.36M Buy
8,159
+909
+13% +$706K 0.59% 37
2025
Q1
$5.99M Buy
7,250
+232
+3% +$193K 0.6% 37
2024
Q4
$5.42M Sell
7,018
-1,314
-16% -$1.09M 0.53% 40
2024
Q3
$7.38M Buy
8,332
+1,620
+24% +$1.46M 0.7% 34
2024
Q2
$6.08M Sell
6,712
-61
-0.9% -$48.8K 0.66% 32
2024
Q1
$5.27M Sell
6,773
-207
-3% -$147K 0.78% 33
2023
Q4
$4.07M Sell
6,980
-181
-3% -$106K 0.63% 42
2023
Q3
$3.85M Buy
7,161
+765
+12% +$394K 0.62% 41
2023
Q2
$3M Sell
6,396
-79
-1% -$33.1K 0.49% 58
2023
Q1
$2.22M Buy
+6,475
New +$2.18M 0.37% 77
2020
Q1
$1.72M Sell
12,368
-632
-5% -$86.8K 0.36% 76
2019
Q4
$1.71M Sell
13,000
-1,304
-9% -$151K 0.29% 93
2019
Q3
$1.6M Buy
14,304
+1,990
+16% +$222K 0.28% 94
2019
Q2
$1.36M Sell
12,314
-390
-3% -$45.9K 0.25% 103
2019
Q1
$1.65M Buy
12,704
+1,068
+9% +$130K 0.32% 93
2018
Q4
$1.35M Sell
11,636
-1,269
-10% -$142K 0.28% 100
2018
Q3
$1.39M Buy
12,905
+585
+5% +$58.5K 0.25% 110
2018
Q2
$1.05M Buy
12,320
+86
+0.7% +$7.06K 0.2% 123
2018
Q1
$947K Buy
12,234
+3,489
+40% +$281K 0.12% 164
2017
Q4
$739K Sell
8,745
-53
-0.6% -$4.51K 0.13% 140
2017
Q3
$753K Sell
8,798
-1,264
-13% -$104K 0.14% 135
2017
Q2
$828K Buy
10,062
+493
+5% +$40.2K 0.17% 127
2017
Q1
$804K Buy
9,569
+306
+3% +$24.5K 0.24% 107
2016
Q4
$681K Buy
9,263
+729
+9% +$54.3K 0.2% 102
2016
Q3
$685K Hold
8,534
0.2% 108
2016
Q2
$672K Sell
8,534
-650
-7% -$48.9K 0.19% 108
2016
Q1
$661K Sell
9,184
-59
-0.6% -$4.46K 0.19% 107
2015
Q4
$779K Hold
9,243
0.24% 96
2015
Q3
$774K Sell
9,243
-825
-8% -$69.6K 0.25% 97
2015
Q2
$841K Sell
10,068
-100
-1% -$7.62K 0.25% 95
2015
Q1
$739K Sell
10,168
-500
-5% -$35.6K 0.22% 102
2014
Q4
$736K Sell
10,668
-350
-3% -$23.6K 0.23% 99
2014
Q3
$715K Buy
11,018
+25
+0.2% +$1.58K 0.24% 97
2014
Q2
$683K Sell
10,993
-77
-0.7% -$4.59K 0.23% 97
2014
Q1
$652K Sell
11,070
-100
-0.9% -$5.58K 0.22% 96
2013
Q4
$570K Sell
11,170
-1,845
-14% -$92.4K 0.2% 103
2013
Q3
$655K Buy
13,015
+1,355
+12% +$70.9K 0.25% 92
2013
Q2
$573K Buy
+11,660
New +$634K 0.22% 96

Other funds holding LLY

Canandaigua National Bank & Trust's LLY Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in Eli Lilly (LLY) in Q2 2026: 7,511 shares worth $9.01M. The stake represents 0.76% of the portfolio and ranks #28 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in LLY as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $9.36M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Canandaigua National Bank & Trust held 7,511 shares of Eli Lilly worth $9.01M as of Q2 2026.
  • Eli Lilly was a new Canandaigua National Bank & Trust position in Q2 2026.
  • Eli Lilly made up 0.76% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #28 holding.
  • Canandaigua National Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
  • Canandaigua National Bank & Trust's Eli Lilly position peaked at $9.36M in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.